Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Cambridge, UK – 10 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral ...

Perspective Therapeutics expects updated data from cohorts 1 & 2 from phase 1/2a study, using VMT-01 in 2H24. Click here to ...

A new form of cancer treatment for melanoma patients has been approved by the FDA, after a clinical trial in St. Louis showed ...

Melanoma, which affects the skin, is one of the most common and serious cancers in the U.S. It can be life-threatening in as ...

An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved ...

Imlygic injections take about 10 minutes and are conducted over several months. In clinical trials, Dr. Gushchin says seven ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

The clinical approach, epidemiology, diagnostic procedures, and management, along with followup of superficial spreading malignant melanoma are discussed. A 45-year-old Caucasian female presented ...

Melanoma is the most serious type of skin cancer. It develops when skin cells multiply rapidly as a consequence of mutations in their DNA caused by UV exposure. Melanomas originate in the pigment ...

(WNDU) - Melanoma is one of the most common and serious cancers in the U.S. It can be life-threatening in as little as 6 weeks. Its tumors can be resistant to many traditional cancer treatments like ...

Cutaneous melanoma (CM) is a highly curable skin cancer of melanocytes if diagnosed early. Unfortunately, its invasion into the deeper dermis increases the risk of it spreading to the lymph nodes ...

Health care practitioners may utilize the ATLAS model to evaluate patients’ signs and symptoms for the early detection of melanoma recurrence.